JBT Marel Q3: Record 18.0% EBITDA Margin, but Material Weaknesses Still Unremediated
JBTM is trading near its 52-week low of $102.97 (15% above the low).
Summary
JBT Marel posted an 18.0% adjusted EBITDA margin and $2.19 adjusted EPS on revenue of $994M, but disclosed that Marel's material weaknesses in IT and journal-entry controls remain unremediated and disclosure controls were not effective at quarter-end.
Key Events · Earnings and Guidance · JBTM
-
Q3 Margins at Record, Revenue Slips
Revenue fell 0.7% to $994M from $1,001M, but adjusted EBITDA rose to $179M for an 18.0% margin, up 90 bps year over year, and adjusted diluted EPS came in at $2.19.
-
Material Weaknesses Remain Unremediated
Marel's IT general controls and journal-entry controls were still deficient at September 30, 2026, and management concluded the company's disclosure controls and procedures were not effective.
-
Cash Generation Strengthens
Nine-month operating cash flow was $320M versus $224M a year earlier, producing free cash flow of $252M after $77M of capital expenditures.
-
Buyback Raised to $700M
The board authorized a $500M increase to the repurchase program on October 30, 2026; the company bought 800,855 shares at an average $117.59 in August 2026.
Analysis · JBTM · Technology
The quarter itself is solid: revenue slipped 0.7% to $994M, yet adjusted EBITDA rose to $179M (18.0% margin, up 90 bps) and adjusted diluted EPS reached $2.19, with nine-month free cash flow of $252M. What changes the risk picture is in Item 4: the IT general controls and journal-entry weaknesses inherited with Marel remained unremediated at September 30, 2026, and the CEO and CFO concluded disclosure controls and procedures were not effective. That statement is a first for this cycle and confirms the acquired business is now inside the assessment scope, keeping a governance overhang on the stock until management can test and certify the fixes. Against that, the board added $500M to the buyback on October 30, 2026, taking total authorization to $700M — a capital-return commitment that partly offsets the controls concern.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, JBTM was trading at $118.06 on NYSE in the Technology sector, with a market capitalization of approximately $6.1B. The 52-week trading range was $102.97 to $170.19. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.